Who owns CANDEL THERAPEUTICS, INC?
- Ticker: CADL
- CUSIP Number: 137404109
Tip: Access positions for across all investors
Analyze quarterly positions in Candel Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Candel Therapeutics stock
Who bought or sold CANDEL THERAPEUTICS, INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Northpond Ventures | 1.9M | $2.8M | 0% | Dec 2023 |
|
| Vanguard Group | 426k | $626k | 5% | Dec 2023 |
|
| Baystate Wealth Management | 77k | $113k | -21% | Dec 2023 |
|
| Citadel Advisors | 17k | $25k | -48% | Dec 2023 |
|
| Two Sigma Securities | 17k | $24k | 100% | Dec 2023 |
|
| Commonwealth Equity Services | 14k | $22k | 100% | Mar 2024 |
|
| UBS Group | 12k | $18k | 119110% | Dec 2023 |
|
| Vontobel Holding | 10k | $15k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 209.00 | $306.749300 | 3% | Dec 2023 |
|
| Wells Fargo & Company | 113.00 | $165.997000 | 5% | Dec 2023 |
|
| Royal Bank of Canada | 30.00 | $0 | -90% | Dec 2023 |
|
| Bank of America Corporation | 18.00 | $25.999200 | 100% | Dec 2023 |
|
Who sold out of Candel Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Franklin Resources | Sep 2023 | 1.1M | $1.0M |
| Empirical Asset Management | Sep 2023 | 10k | $9.2k |